Clincosm LogoSign in Get a demo

Use of the Nasal Cannula During COVID-19

Sponsor
Tiva Group (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04376580
Collaborator
(none)
100
Enrollment
1
Location
7
Anticipated Duration (Months)
14.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The objective of this investigation is to determine the incidence of the use of the low flow nasal cannula in suspected or confirmed cases with Covid-19

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    An anonymous questionnaire will be sent to a group of anesthesiologists via email which will allow to collect information about the use, or not, of the low flow nasal cannula, the type of procedure where it is used, and the type of personal protection weared.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    100 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Prospective
    Official Title:
    Incidence and Implications With the Use of Nasal Cannulas During COVID-19
    Actual Study Start Date :
    Apr 30, 2020
    Anticipated Primary Completion Date :
    Oct 31, 2020
    Anticipated Study Completion Date :
    Nov 30, 2020

    Outcome Measures

    Primary Outcome Measures

    1. Number of physician using los flow nasal cannula during COVID 19 pandemia [1 month]

      We'll send by email a link with an online quiz to a Group of physicians with questions related to the use of nasal cannula during their routine practice.

    Secondary Outcome Measures

    1. Number of physician getting sick during Covid 19 pandemic [1 month]

      We'll send by email a link with an online quiz to a group of physicians with questions related to the use of nasal cannula during their routine practice, and one of the questions is about if the physician was getting sick during the Covid pandemic.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • only for physicians
    Exclusion Criteria:
    • not physicians

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Carolina Frederico Buenos Aires Caba Argentina 1428

    Sponsors and Collaborators

    • Tiva Group

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Carolina Frederico, Carolina Frederico A., Tiva Group
    ClinicalTrials.gov Identifier:
    NCT04376580
    Other Study ID Numbers:
    • Nasal cannulas flow rate
    First Posted:
    May 6, 2020
    Last Update Posted:
    Oct 6, 2020
    Last Verified:
    Oct 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Carolina Frederico, Carolina Frederico A., Tiva Group
    Low flow nasal cannula
    Anesthesia
    Sedation
    Regional Anesthesia
    Additional relevant MeSH terms:
    COVID-19

    Study Results

    No Results Posted as of Oct 6, 2020